ORPHA:169808
Mild hemophilia A
Also known as: Mild congenital F8 deficiency · Mild congenital factor VIII deficiency
Publications
1,219
Trials
3
Interventional, condition-specific
Researchers
1,151
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A mild form of hemophilia A characterized by a small deficiency of factor VIII (biological activity between 5 and 40 IU/dL) leading to abnormal bleeding as a result of minor injuries or following surgery or tooth extraction. Spontaneous hemorrhages do not occur. Patients may be also labeled as having mild hemophilia A if they have a FVIII >40 IU/dL and a DNA change in the F8 gene and one of the following: (i) a family member with the same DNA change and FVIII of <40 IU/dL, and the DNA change is found in <1% of the population; and (ii) the international databases list the DNA change as being associated with hemophilia A and <40 IU/dL FVIII. The condition may affect males and female carriers of disease-causing mutations.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015721
- UMLS:C0272324
Additional Mondo synonyms (3)
mild factor VIII deficiency · mild haemophilia type A · mild hemophilia type A
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,219 matched papers (704 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationPartial
1 FDA designation (none yet with FDA orphan-indication approval) — e.g. Desmopressin acetate Source
- Interventional trialPresent
3 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
1
Designation · no FDA orphan-indication approval yet
- FDA Desmopressin acetatevon Willebrand's Disease Mild hemophilia A · 1991-01-22
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,219
1,219 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,219 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
704 in the last 10 years · low confidence
Phrase hits: 1,219 · MeSH hits: 0
Who's working on it?
1,151
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Fijnvandraat K10 papers · 2025
Pediatric Hematology Amsterdam UMC Emma Children's Hospital University of Amsterdam Amsterdam The Netherlands.
Papers in Europe PMC - 02Coppens M9 papers · 2025
Department of Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, the Netherlands.
Papers in Europe PMC - 03Leebeek FWG9 papers · 2025
Department of Hematology, Erasmus MC, Rotterdam, the Netherlands.
Papers in Europe PMC - 04Castaman G8 papers · 2025
Department of Oncology Center for Bleeding Disorders Careggi University Hospital Florence Italy.
Papers in Europe PMC - 05Gouw SC7 papers · 2023
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Papers in Europe PMC - 06Pabinger I7 papers · 2025
Clinical Division of Hematology and Hemastaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Papers in Europe PMC - 07Hermans C6 papers · 2026
Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), 1200 Brussels, Belgium. Electronic address: cedric.hermans@uclouvain.be.
Papers in Europe PMC - 08Nogami K6 papers · 2026
Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
Papers in Europe PMC - 09Peyvandi F6 papers · 2026
Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
Papers in Europe PMC - 10Beckers EAM5 papers · 2023
Department of Hematology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
3
interventional trials for this specific condition
3 interventional trials matched this specific condition name; 1 currently recruiting in our sample. 332 trials are registered for hemophilia A, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
3 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 86.7th percentile).
low confidence · 86.7th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
3 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT04567511·RECRUITING·Hemlibra in Mild Hemophilia A
Not reviewed·Conditions: Factor VIII Deficiency, Congenital·Matched via name phrase
Broader category: hemophilia A
332
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06816056·RECRUITING·Manual Therapy in Hemophilic Arthropathy of the Ankle
Not reviewed·Conditions: Hemophilia A·Matched via name phrase
- NCT06145373·RECRUITING·A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Not reviewed·Conditions: Hemophilia A·Matched via name phrase
- NCT05611801·RECRUITING·A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Not reviewed·Conditions: Hemophilia A · Hemophilia B·Matched via name phrase
- NCT05145127·RECRUITING·Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Not reviewed·Conditions: Hemophilia A · Hemophilia B·Matched via name phrase
- NCT07421154·NOT YET RECRUITING·Study of a Smart Sharps Disposal Device in Patients With Hemophilia
Not reviewed·Conditions: Hemophilia A and B·Matched via name phrase
- NCT07545395·RECRUITING·Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
Not reviewed·Conditions: Hemophilia A or B·Matched via name phrase
- NCT07200609·NOT YET RECRUITING·The Effects of Virtual Reality-Based Gamified Rehabilitation in Children With Hemophilia
Not reviewed·Conditions: Hemophilia A Without Inhibitor·Matched via name phrase
- NCT03217032·RECRUITING·Lentiviral FVIII Gene Therapy
Not reviewed·Conditions: Hemophilia A·Matched via name phrase
- NCT07416526·RECRUITING·A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Not reviewed·Conditions: Hemophilia A·Matched via name phrase
- NCT07285460·RECRUITING·A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Not reviewed·Conditions: Hemophilia·Matched via name phrase
- NCT07226206·RECRUITING·A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Not reviewed·Conditions: Hemophilia A·Matched via name phrase
- NCT06864975·RECRUITING·Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)
Not reviewed·Conditions: Hemophilia a with Inhibitor·Matched via name phrase
- NCT04728841·RECRUITING·Gene Therapy for Chinese Hemophilia A
Not reviewed·Conditions: Hemophilia A · Gene Therapy·Matched via name phrase
- NCT06320626·RECRUITING·Pharmacokinetic-guided Dosing of Emicizumab
Not reviewed·Conditions: Hemophilia A With Inhibitor · Hemophilia A Without Inhibitor · Hemophilia A, Severe · Adolescent·Matched via name phrase
- NCT06938659·NOT YET RECRUITING·Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients
Not reviewed·Conditions: Hemophilia A·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 3 · after dedupe 3 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 3 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (3)
- isrctn·ISRCTN15852459·No longer recruiting·Diode laser-assisted tooth extraction versus conventional extraction in patients receiving antiplatelet therapy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10708719·No longer recruiting·Shoulder pain: To needle or not to needle? The role of acupuncture in the treatment of shoulder pain
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN34508212·No longer recruiting·Mild induced hypothermia for severe falciparum malaria
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Mild hemophilia A — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Mild hemophilia A" OR "Mild congenital F8 deficiency" OR "Mild congenital factor VIII deficiency" OR "mild factor VIII deficiency" OR "mild haemophilia type A" OR "mild hemophilia type A"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Mild hemophilia A" OR "Mild congenital F8 deficiency" OR "Mild congenital factor VIII deficiency" OR "mild factor VIII deficiency" OR "mild haemophilia type A" OR "mild hemophilia type A"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 3 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"hemophilia A"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1219) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T08:38:36.957Z
